Figure 2.

Model schematic for adverse events^b in an antiretroviral therapy-naïve HIV-1-infected adult US population.

Notes: ^aRash, renal abnormalities, central nervous system symptoms, and other events causing discontinuation of treatment; ^bpatients who began to receive lipid-lowering therapy (because of elevated lipids) did not discontinue treatment and faced added costs of lipid-lowering therapy.

Abbreviations: AKI, acute kidney injury; CKD, chronic kidney disease; HIV, human immunodeficiency virus.